Blutspenderauswahl zur Bereitstellung von anti-Cytomegalievirus-negativen Blutkomponenten
- 1 January 1989
- journal article
- research article
- Published by Georg Thieme Verlag KG in Deutsche Medizinische Wochenschrift (1946)
- Vol. 114 (06) , 203-207
- https://doi.org/10.1055/s-2008-1066576
Abstract
Sera of 1731 blood donours of the Ulm blood bank were screened for cytomegalovirus (CMV) antibodies. Prevalence of these antibodies was 37%. The seroconversion rate among 1090 anti-CMV-negative blood donours was 13 per thousand per year for the whole donour population over a period of 27 months and depended on age. It was 16 per thousand per year for donours aged 18-40 years, but only 7 per thousand for those over 41 years old. Seropositivity was higher in women than men. To provide anti-CMV-negative blood requires a pre-screened anti-CMV-negative donour group and the re-screening of each further donated blood component.This publication has 5 references indexed in Scilit:
- Cytomegalovirus Immune Globulin and Seronegative Blood Products to Prevent Primary Cytomegalovirus Infection after Marrow TransplantationNew England Journal of Medicine, 1986
- Use of Deglycerolized Red Blood Cells to Prevent Posttransfusion Infection with Cytomegalovirus in NeonatesThe Journal of Infectious Diseases, 1984
- Prevention of transfusion‐associated cytomegalovirus infection in very low‐birthweight infants using frozen blood and donors seronegative for cytomegalovirusTransfusion, 1984
- Prevention of transfusion-acquired cytomegalovirus infections in newborn infantsThe Journal of Pediatrics, 1981
- Reduction of Postperfusion Cytomegalovirus‐Infections following the Use of Leukocyte Depleted BloodTransfusion, 1977